Cramer: Nike earnings are 'Jordan shoe on steroids'

CNBC's Jim Cramer explains how Nike was able to beat analysts' estimates so handily.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.